ストックスクリーナーアプリを入手
0.6302
5.94%
-0.0398
プレマーケット:
.63
-0.0002
-0.03%
前日終値:
$0.67
開ける：
$0.647
24時間の取引高:
55,298
Relative Volume:
0.49
時価総額：
$10.73M
収益：
$2.82M
当期純損益:
$-14.20M
株価収益率:
-0.7414
EPS:
-0.85
ネットキャッシュフロー:
$-15.13M
1週間 パフォーマンス:
+8.66%
1か月 パフォーマンス:
-0.80%
6か月 パフォーマンス:
-27.56%
1年 パフォーマンス:
-28.39%
1日の値動き範囲:
$0.63
$0.6945
1週間の範囲:
$0.5511
$0.6945
52週間の値動き範囲:
$0.501
$1.61
Talphera Inc Stock (TLPH) Company Profile
TLPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.6302 | 10.73M | 2.82M | -14.20M | -15.13M | -0.85 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-07-20 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | 再開されました | Credit Suisse | Outperform |
| 2019-07-10 | 再開されました | Credit Suisse | Outperform |
| 2019-04-24 | 再開されました | B. Riley FBR | Buy |
| 2019-02-15 | 開始されました | Credit Suisse | Outperform |
| 2018-10-23 | 開始されました | B. Riley FBR | Buy |
| 2017-10-13 | ダウングレード | Jefferies | Buy → Hold |
| 2017-10-13 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-07-14 | 再開されました | Jefferies | Buy |
| 2016-09-15 | 繰り返されました | ROTH Capital | Buy |
| 2016-08-05 | ダウングレード | Stifel | Buy → Hold |
| 2015-10-30 | アップグレード | Jefferies | Hold → Buy |
| 2015-10-05 | 繰り返されました | ROTH Capital | Buy |
| 2015-09-02 | 開始されました | H.C. Wainwright | Buy |
| 2015-07-10 | 再開されました | ROTH Capital | Buy |
| 2015-05-06 | 繰り返されました | Mizuho | Neutral |
| 2015-05-05 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2015-03-10 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2015-03-09 | ダウングレード | Mizuho | Buy → Neutral |
すべてを表示
Talphera Inc (TLPH) 最新ニュース
FDA to review Talphera's request to amend NEPHRO study By Investing.com - Investing.com Canada
FDA to review Talphera’s request to amend NEPHRO study By Investing.com - Investing.com Nigeria
FDA to review Talphera's request to amend NEPHRO study - Investing.com
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - Marketscreener.com
TLPH stock touches 52-week low at $0.6 amid market shifts - Investing.com UK
TLPH stock touches 52-week low at $0.61 amid market challenges - Investing.com
Talphera faces Nasdaq delisting over share price rule - Investing.com
Talphera faces Nasdaq delisting over share price rule By Investing.com - Investing.com UK
Acelrx Announces Dsuvia® Milestone C Approval; Provides Revenue Guidance for the First Quarter 2020 - Marketscreener.com
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - Kilgore News Herald
Talphera CEO Vincent J. Angotti acquires $3,199 in common stock - Investing.com
Talphera CEO Vincent J. Angotti acquires $3,199 in common stock By Investing.com - Investing.com UK
Talphera CEO Vincent J. Angotti buys $3,649 in company stock By Investing.com - Investing.com Canada
Talphera CFO Raffi Asadorian sells shares worth $118 - Investing.com India
Talphera CEO Vincent J. Angotti buys $3,649 in company stock - Investing.com India
Talphera CFO Raffi Asadorian sells shares worth $118 By Investing.com - Investing.com Canada
Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023) - Yahoo Finance
Talphera (FRA:R5XA) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - Yahoo Finance
Talphera: Q3 Earnings Snapshot - mySA
Talphera Reports Q3 2024 Results and Study Progress - TipRanks
Talphera's Q3 Loss Widens to $3.4M as NEPHRO Trial Expands to New Sites | TLPH Stock News - StockTitan
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire
An Overview of Talphera's Earnings - Benzinga
Talphera Sets Q3 2024 Earnings Call for November 13Key Financial Results Update | TLPH Stock News - StockTitan
Talphera, Inc. (NASDAQ:TLPH) Sees Large Decline in Short Interest - Defense World
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Citizentribune
Talphera extends agreement deadline with Nantahala Management By Investing.com - Investing.com Australia
Talphera extends agreement deadline with Nantahala Management - Investing.com
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald
Talphera CEO Vincent J. Angotti buys $7.6k in company stock - Investing.com
Credit Suisse gives an Underperform recommendation for Talphera Inc. (TLPH) - Knox Daily
TLPH Stock Earnings: Talphera Beats EPS for Q2 2024 - MSN
Talphera starts key trial for anticoagulant nafamostat - Investing.com India
Talphera starts key trial for anticoagulant nafamostat By Investing.com - Investing.com Canada
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - PR Newswire
Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023) - Yahoo Finance
Talphera Inc (TLPH) Q2 2024 Earnings Call Transcript Highlights: Strategic Advancements and Financial Adjustments - GuruFocus.com
Talphera: Q2 Earnings Snapshot - San Antonio Express-News
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update - Longview News-Journal
Talphera, Inc. (NASDAQ:TLPH) Q2 2024 Earnings Call Transcript - MSN
Talphera Announces CMO Retirement and Successor Appointment - TipRanks
Talphera Inc (TLPH) 財務データ
収益
当期純利益
現金流量
EPS
2.14%
大文字化:
|
ボリューム (24 時間):